ThematIQ

Gene editing

Investor interest4

ETFs follow Genomics, with $2.7bn

ETFIQ, 28 Oct 2026
Build a strategy from Gene editing

This sub-theme's bill of materials has not been built yet. It is drafted, researched and shared with every user the first time someone builds it in ThematIQ Studio.

Questions

What is Gene editing?
A sub-theme of Genomics.

Not investment advice. Figures are dated and sourced; ThematIQ does not estimate figures it cannot source.